England’s frontline doctors are to get help to deal with the growing demands of the job, which has led many to leave the profession, develop mental health problems or turn to alcohol to dea
Biogen has scaled back its ambitions for Denali-partnered Parkinson’s disease candidate BIIB122, abandoning a complex and likely costly phase 3 trial that isn’t due to com
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas
